The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Coexistence of multiple sclerosis and ankylosing spondylitis: report of two cases.

TitleCoexistence of multiple sclerosis and ankylosing spondylitis: report of two cases.
Publication TypeJournal Article
Year of Publication2013
AuthorsLourbopoulos, A., Ioannidis P., Boura E., Antoniadis D., Karacostas D., & Grigoriadis N.
JournalEur Neurol
Volume70
Issue3-4
Pagination149-54
Date Published2013
ISSN1421-9913
KeywordsAdult, Brain, Comorbidity, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Spinal Cord, Spondylitis, Ankylosing
Abstract

BACKGROUND: Multiple sclerosis (MS) only rarely coexists with ankylosing spondylitis (AS). The optimal management of these patients represents a major challenge.METHODS: In the present study, we report 2 cases of AS with definite MS comorbidity. One of the AS-MS cases had received anti-TNFα treatment, which was discontinued due to exacerbation of the MS. In addition, we discuss 3 more AS cases with neurological symptoms and atypical white matter demyelinating MRI lesions after anti-TNFα treatment.DISCUSSION: Given the fact that anti-TNFα drugs can potentially exacerbate a latent MS or induce atypical demyelination in the central nervous system, they should be discouraged or discontinued in relevant cases. The remaining effective therapeutic options for MS are either contradictory for AS (interferon-β), have no definite data regarding their safety/efficacy in AS (glatiramer acetate, azathioprine, natalizumab, fingolimod), or their efficacy in MS-AS is associated with increased treatment risks (rituximab). Any of these proposed treatments may require active patient's informed consent.

DOI10.1159/000351248
Alternate JournalEur. Neurol.
PubMed ID23921512

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.